Congestive heart failure in childhood and adolescence: recognition and management.
D000293:Adolescent; D002216:Captopril / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000175:diagnosis; D002648:Child; D004077:Digoxin / Q000627:therapeutic use; D004280:Dobutamine / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D004452:Echocardiography; D004562:Electrocardiography; D004697:Endocarditis, Bacterial / Q000175:diagnosis; D005665:Furosemide / Q000627:therapeutic use; D006321:Heart / Q000000981:diagnostic imaging; D006330:Heart Defects, Congenital / Q000175:diagnosis; D006331:Heart Diseases / Q000175:diagnosis; D006333:Heart Failure / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D007545:Isoproterenol / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D010808:Physical Examination; D011877:Radionuclide Imaging; D012214:Rheumatic Heart Disease / Q000175:diagnosis
D009599:Nitroprusside; D006830:Hydralazine; D004280:Dobutamine; D004077:Digoxin; D005665:Furosemide; D002216:Captopril; D007545:Isoproterenol; D004298:Dopamine